Given this overlap, we utilized patient depression scores (BDI) as the outcome for ARACNE analysis to test the hypothesis that PER3-VNTR, CRY1, and ZBTB20 are directly involved in mood regulation. The gene discussed is CRY1; the disease is depressive symptom measurement.